A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension.
Nadine Arnold(University of Sheffield), Allan Lawrie(University of Sheffield)
Cited by 0
Related Papers
MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension
|Journal of Clinical Investigation|2016|148
Inhibition of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension
|The Journal of Experimental Medicine|2012|94
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension
|Nature Communications|2019|34